Repligen (RGEN) Posts Q4 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.37 --0%
EPS Growth %: +21.6%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +21.6%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $14.7 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
